ANGION BIOMEDICA CORP (ANGN)

US03476J1079 - Common Stock

1  +0.02 (+2.04%)

After market: 0.9437 -0.06 (-5.63%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
2.88M
93.29%		28.312M
883.06%		2.301M
-91.87%
EBITDA
YoY % growth
-55.17M
-43.15%		-39.216M
28.92%		-30.258M
22.84%		-41.83M
-38.25%		N/A
EBIT
YoY % growth
-55.27M
-43.22%		-39.307M
28.88%		-30.436M
22.57%		-25.5M
16.22%
Operating Margin
-1,919.10%-138.84%-1,322.73%N/A
EPS
YoY % growth
N/A-2.09-1.29
38.28%		-0.85
34.37%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth		 -0.21
-136.21%		-0.210.001.96%
Q3 2022
Q2Q % growth		 -0.30
43.40%		-0.370.0718.30%
Q2 2022
Q2Q % growth		 -0.30
48.28%		-0.470.1736.52%
Q1 2022
Q2Q % growth		 -0.48
69.23%		-0.44-0.04-8.18%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
-100.00%		%
Q3 2022
Q2Q % growth
-100.00%		833.003K-833.003K-100.00%
Q2 2022
Q2Q % growth		 653K
20.93%		1.377M-724K-52.58%
Q1 2022
Q2Q % growth		 1.648M
345.41%		937.125K710.875K75.86%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A N/A N/A